Evidence map›Paper›PMID 27917863›Full record

ArticleScientific reports2016

DNA intercalation optimized by two-step molecular lock mechanism.

Ali A Almaqwashi, Johanna Andersson, Per Lincoln, Ioulia Rouzina, Fredrik Westerlund, Mark C Williams

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Minimal Load-and-Lock RuAngewandte Chemie (International ed. in English) · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Ali A AlmaqwashiDepartment of Physics, Northeastern University, Boston, MA, 02115, USA.
Johanna AnderssonDepartment of Chemistry-BMC, Uppsala University, Uppsala, SE-75123, Sweden.
Per LincolnDepartment of Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, SE-41296, Sweden.
Ioulia RouzinaDepartment of Chemistry and Biochemistry, Ohio State University, Columbus, OH, 43210, USA.
Fredrik WesterlundDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, SE-41296, Sweden.
Mark C WilliamsDepartment of Physics, Northeastern University, Boston, MA, 02115, USA.
Chalmers University of Technology · SENortheastern University · USThe Ohio State University · US

Funding

Single Molecule HIV-1 Replication InteractionsR01GM072462 · NIGMS · NORTHEASTERN UNIVERSITY · PI WILLIAMS, MARK C · 2004 to 2018
$3.9M
NIGMS NIH HHS R01 GM072462
6 · The paper itself

Abstract

The diverse properties of DNA intercalators, varying in affinity and kinetics over several orders of magnitude, provide a wide range of applications for DNA-ligand assemblies. Unconventional intercalation mechanisms may exhibit high affinity and slow kinetics, properties desired for potential therapeutics. We used single-molecule force spectroscopy to probe the free energy landscape for an unconventional intercalator that binds DNA through a novel two-step mechanism in which the intermediate and final states bind DNA through the same mono-intercalating moiety. During this process, DNA undergoes significant structural rearrangements, first lengthening before relaxing to a shorter DNA-ligand complex in the intermediate state to form a molecular lock. To reach the final bound state, the molecular length must increase again as the ligand threads between disrupted DNA base pairs. This unusual binding mechanism results in an unprecedented optimized combination of high DNA binding affinity and slow kinetics, suggesting a new paradigm for rational design of DNA intercalators.

Indexed as

DNAIntercalating AgentsKineticsModels, MolecularNucleic Acid ConformationSingle Molecule ImagingDNAIntercalating Agents

Identifiers

PMID27917863
PMCPMC5137138
OpenAlexW2560405345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.